临床试验

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

NCT：NCT04502316 · TERMINATED

NCT编号NCT04502316

状态TERMINATED

开始日期2020-06-26

完成时间2026-06-30

SponsorCVRx, Inc. (INDUSTRY)

First posted2020-08-06

Last updated2026-09-17

简要摘要

The purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。